Drug Type Small molecule drug |
Synonyms PRN 473, SAR-444727 |
Target |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H30FN7O2 |
InChIKeyKZMQPYCXSAGLTB-ZWUNQBBJSA-N |
CAS Registry1581714-49-9 |
Start Date25 Jun 2020 |
Sponsor / Collaborator |
Start Date08 Mar 2020 |
Sponsor / Collaborator |
Start Date01 Sep 2013 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Phase 1 | AU | 22 Feb 2020 | |
Arthritis | Phase 1 | AU | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |